CTOR

Citius Oncology
CTOR

Overview Fund Trends Analyst Outlook Journalist POV
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$6
233% upside
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Maxim Group
Maxim Group
Michael Okunewitch
50% 1-yr CTOR win rate
23 Sep ‘25 24 days ago